Twist Bioscience CORP Form 4 insider transactions

Twist Bioscience Corp.'s Chief Accounting Officer, Robert F. Werner, sold 839 shares of common stock for $27.728 per share to satisfy tax withholding obligations related to Restricted Stock Unit vesting.

Twist Bioscience Corporation's CEO, Emily M. Leproust, sold 2,802 shares of common stock at $29.747 per share to satisfy tax withholding obligations related to the vesting of Restricted Stock Units.

Dennis Cho, Senior Vice President, Chief Legal Officer & Corporate Secretary of Twist Bioscience Corp, sold 531 shares of common stock to satisfy tax withholding obligations related to vested restricted stock units.

Paula Green, SVP of Human Resources at Twist Bioscience Corp, sold 632 shares of common stock at $29.747 per share to satisfy tax withholding obligations related to Restricted Stock Unit vesting.

Patrick John Finn, President and COO of Twist Bioscience Corp., sold 1,877 shares of common stock at $29.747 per share to cover tax withholding obligations related to Restricted Stock Units vesting, a non-discretionary transaction.

Twist Bioscience's Chief Accounting Officer, Robert F. Werner, sold 242 shares of common stock for $29.747 per share to satisfy tax withholding obligations related to the vesting of Restricted Stock Units.

Twist Bioscience Chief Financial Officer Adam Laponis sold 936 shares of common stock for tax withholding purposes related to restricted stock unit vesting.

Patrick John Finn, President and COO of Twist Bioscience Corp, sold 20,000 shares of common stock at an average price of $32.313 on May 8, 2025.

CEO Emily Leproust reported a gift of 3,000 shares to a charitable donor-advised fund and detailed her holdings of Twist Bioscience stock options.

Dennis Cho, a Senior Vice President at Twist Bioscience, sold 5,000 shares of common stock on May 7, 2025, at an average price of $32.718 per share.

Dennis Cho, a Senior Vice President at Twist Bioscience, sold 689 shares of common stock on May 5, 2025, to cover tax withholding obligations related to vesting Restricted Stock Units.

Patrick John Finn, President and COO of Twist Bioscience, sold 2,800 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Robert F. Werner, Chief Accounting Officer of Twist Bioscience Corp, sold 162 shares of common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Paula Green, SVP of Human Resources at Twist Bioscience, sold 1,101 shares of common stock on May 5, 2025, to cover tax withholding obligations related to vesting Restricted Stock Units.

CEO of Twist Bioscience, Emily Leproust, sold 5,042 shares of common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Patrick John Finn, President and COO of Twist Bioscience Corp., sold shares to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Adam Laponis, CFO of Twist Bioscience, sold 2,542 shares of common stock on April 9, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Dennis Cho, a Senior Vice President at Twist Bioscience, sold shares to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Patrick John Finn, President and COO of Twist Bioscience, sold 206 shares of common stock on April 2, 2025, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Paula Green, SVP of Human Resources at Twist Bioscience, sold 140 shares of common stock on April 2, 2025, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Emily Leproust, CEO of Twist Bioscience, sold 492 shares of common stock on April 2, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Dennis Cho, a Senior Vice President at Twist Bioscience, sold 230 shares of common stock on March 20, 2025, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Paula Green, SVP of Human Resources at Twist Bioscience, sold 291 shares of common stock on March 20, 2025, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Emily Leproust, CEO of Twist Bioscience, sold shares to cover tax withholding obligations related to vesting Restricted Stock Units on March 20, 2025.

Dennis Cho, a Senior Vice President at Twist Bioscience, sold shares to cover tax withholding obligations related to the vesting of restricted stock units.

Paula Green, SVP of Human Resources at Twist Bioscience, sold 918 shares of common stock on March 6, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Dennis Cho, a Senior Vice President at Twist Bioscience, sold shares to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Emily Leproust, CEO of Twist Bioscience, sold 2,402 shares of common stock at $40.913 per share to cover tax withholding obligations related to vesting Restricted Stock Units.

Robert F. Werner, Chief Accounting Officer of Twist Bioscience Corp, sold 241 shares of common stock to cover tax withholding obligations related to vesting Restricted Stock Units.

Robert F. Werner, Chief Accounting Officer of Twist Bioscience Corp, sold shares of common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units.